Tenon Medical, Inc. Proceeds from Convertible Debt
Tenon Medical, Inc. (TNON) reported Proceeds from Convertible Debt of $4.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2026-08-13
- Tenon Medical, Inc. proceeds from convertible debt for the quarter ending 2026-06-30 was $0.00.
- Tenon Medical, Inc. proceeds from convertible debt for the quarter ending 2026-03-31 was $4.30M.
- Tenon Medical, Inc. proceeds from convertible debt for the quarter ending 2022-12-31 was $0.00.
- Tenon Medical, Inc. proceeds from convertible debt for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Tenon Medical, Inc. proceeds from convertible debt for fiscal 2023 was $1.25M.
- Tenon Medical, Inc. proceeds from convertible debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Tenon Medical, Inc. proceeds from convertible debt for fiscal 2021 was $12.07M.
| Period end | Proceeds from Convertible Debt 1 month | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.30M 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $4.30M 10-Q · filed 2026-05-15 | ||||
| 2023-12-31 | $1.25M 10-K · filed 2025-03-26 | ||||
| 2023-11-30 | $1.25M 10-K · filed 2025-03-26 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $0.00 derived: sum of 2 quarters · filed 2023-03-10 | $0.00 10-K · filed 2023-03-10 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $3.94M derived: sum of 2 quarters · filed 2023-03-10 | $12.07M 10-K · filed 2023-03-10 | ||
| 2021-09-30 | $3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $12.07M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $8.13M 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |